Document Detail


Paclitaxel therapy potentiates cold hyperalgesia in streptozotocin-induced diabetic rats through enhanced mitochondrial reactive oxygen species production and TRPA1 sensitization.
MedLine Citation:
PMID:  22177224     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Diabetes comorbidities include disabling peripheral neuropathy (DPN) and an increased risk of developing cancer. Antimitotic drugs, such as paclitaxel, are well known to facilitate the occurrence of peripheral neuropathy. Practitioners frequently observe the development or co-occurrence of enhanced DPN, especially cold sensitivity, in diabetic patients during chemotherapy. Preclinical studies showed that reactive oxygen species (ROS) and cold activate transient receptor potential ankyrin-1 (TRPA1) cation channels, which are involved in cold-evoked pain transduction signaling in DPN. Additionally, paclitaxel treatment has been associated with an accumulation of atypical mitochondria in the sensory nerves of rats. We hypothesized that paclitaxel might potentiate cold hyperalgesia by increasing mitochondrial injuries and TRPA1 activation. Thus, the kinetics of paclitaxel-induced cold hyperalgesia, mitochondrial ROS production, and TRPA1 expression were evaluated in dorsal root ganglia of normoglycemic and streptozotocin-induced diabetic rats. In diabetic rats, paclitaxel significantly enhanced cold hyperalgesia in comparison to normoglycemic paclitaxel-treated control rats. These effects were prevented by N-acetyl-cysteine, a reducing agent, and by HC030031, an antagonist of TRPA1. In diabetic and control rats, paclitaxel treatment was associated with an accumulation of atypical mitochondria and a 2-fold increase in mitochondrial ROS production. Moreover, mRNA levels of glutathione peroxidase 4 and glutathione-S-reductase were significantly lower in diabetic groups treated with paclitaxel. Finally, TRPA1 gene expression was enhanced by 45% in diabetic rats. Paclitaxel potentiation of cold hyperalgesia in diabetes may result from the combination of increased mitochondrial ROS production and poor radical detoxification induced by paclitaxel treatment and diabetes-related overexpression of TRPA1.
Authors:
David André Barrière; Jennifer Rieusset; Didier Chanteranne; Jérôme Busserolles; Marie-Agnès Chauvin; Laëtitia Chapuis; Jérôme Salles; Claude Dubray; Béatrice Morio
Related Documents :
18378574 - Role of nadph oxidase in retinal vascular inflammation.
16320154 - Early loss of arteriolar smooth muscle cells: more than just a pericyte loss in diabeti...
21514434 - Long-term administration of the histone deacetylase inhibitor vorinostat attenuates ren...
9374254 - Cataract surgery and pupil size in patients with diabetes mellitus.
10440134 - Homozygosity of the pro12ala variant of the peroxisome proliferation-activated receptor...
8550854 - Comparison of the time courses of insulin and the portal signal on hepatic glucose and ...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-12-14
Journal Detail:
Title:  Pain     Volume:  -     ISSN:  1872-6623     ISO Abbreviation:  -     Publication Date:  2011 Dec 
Date Detail:
Created Date:  2011-12-19     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7508686     Medline TA:  Pain     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2011 International Association for the Study of Pain. Published by Elsevier B.V. All rights reserved.
Affiliation:
Pharmacologie Fondamentale et Clinique de la Douleur, Clermont Université, Université d'Auvergne, BP 10448, F-63000 Clermont-Ferrand, France; U766, INSERM [National Institute of Health and Medical Research], F-63000 Clermont-Ferrand, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Energy levels and crystal field parameters for Nd(3+) ions in BaY(2)F(8), LiKYF(5), and K(2)YF(5) si...
Next Document:  Characterization of interactions between Escherichia coli O157:H7 with epiphytic bacteria in vitro a...